Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

404

Not found

This newslink doesn't exist or it was removed.

Go to Homempage.

Sugerencias de la Hemeroteca

Alnylam Stock Is Dropping on Surprising FDA Rejection

MarketWatch USA Business October 09, 2023

thumbnailAlnylam said in a Monday morning that the FDA had not been satisfied by the clinical meaningfulness of the drug’s efficacy. An approval in the cardiomyopathy indication could have meant a significant boost to Alnylam sales, which were $1 billion in 2022. Far more patients... + más

Alnylam signs $2.8 billion deal with Roche to advance Cambridge biotech’s injection for high blood pressure | The Boston Globe

Alnylam deploys gene-silencing in early study aimed at subduing Alzheimer’s | The Boston Globe


Meet Helios, a new class of space tug with some real muscle

Ars Technica USA Science January 17, 2024

thumbnailNavigate Filter by topic Settings Front page layout Site theme - Jan 17, 2024 2:00 pm UTC / Artist's concept of the Helios space tug.Impulse Space In recent years there have been a number of modest 'tugs' brought online to ferry small satellites to designated... + más

Ex-Dividend Reminder: Cisco Systems, NetApp And Helios Technologies | Forbes

How to pair a new or existing Apple Watch with your new iPhone [New process] | 9to5Mac


Ex-Dividend Reminder: Cisco Systems, NetApp And Helios Technologies

Forbes USA Business January 03, 2023

thumbnailOn 1/4/23, Cisco Systems, NetApp, and Helios Technologies will all trade ex-dividend for their respective upcoming dividends. Cisco Systems will pay its quarterly dividend of $0.38 on 1/25/23, NetApp, Inc. will pay its quarterly dividend of $0.50 on 1/25/23, and Helios... + más

How To Calculate Dividend Yield | Forbes

What Are Dividend Stocks? | Forbes


NeuroSense Says Phase 2b ALS Trial Meets Primary And Secondary Endpoints

RTTNews USA Health December 05, 2023

thumbnailNeuroSense Therapeutics Ltd. () announced Tuesday that it met its primary safety and tolerability endpoints and achieved secondary clinical efficacy endpoints in the top-line results of its 6-month, randomized, placebo-controlled, double-blind segment the Company's Phase 2b... + más

NFL Playoff Scenarios | ABC News

What is ALS? Experts explain symptoms to look out for, causes and treatments | CBS News


Ex-MoviePass CEOs charged with scheming to defraud investors

Los Angeles Times USA Business November 05, 2022

thumbnailTwo former MoviePass Inc. executives were charged with securities and wire fraud for allegedly scheming to defraud investors of the parent of the bankrupt company. Theodore Farnsworth, 60, of Miami, and J. Mitchell Lowe, 70, of Miami Beach, are accused of making false... + más

Federal Prosecutors Charge Ex-CEOs of MoviePass, Parent Company in Alleged Fraud Scheme | NBC 6 South Florida

SEC sues former MoviePass executives for alleged fraud and misleading investors | Los Angeles Times



About iurex | Privacy Policy | Disclaimer |